Skip to main content
. Author manuscript; available in PMC: 2012 Sep 6.
Published in final edited form as: Nat Med. 2004 Sep 19;10(10):1095–1103. doi: 10.1038/nm1105

Figure 3.

Figure 3

Role of IL-13 in the VEGF phenotype. (a) RT-PCR was used to evaluate the levels of IL-13 mRNA in lung RNA from wild-type (WT) and transgenic (TG) mice given dox for 1 month. (bd) Ability of VEGF to induce mucus metaplasia (×20), pulmonary fibrosis and AHR, respectively, are compared in mice with wild-type (Il13+/+) and null mutant (Il13−/−) loci. The arrows in b highlight positive-staining cells. In c, *P < 0.01 versus VEGF mice. In d, *P < 0.05 versus VEGF controls.